US › Healthcare

Owlet Inc (OWLT)

US · Healthcare · Medical Devices

$5.34-1.66%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$22.5M
Revenue YoY
+6.4%
Net profit
$-3.3M
Profit YoY
-210.3%
EPS
$-0.09
EPS estimate
$-0.19
Net margin
-14.9%

EPS came in at -0.09 against a street estimate of -0.19 — a beat of 52.6%.

Key statistics

Market cap
$149.4M
Forward P/E
0.0
P/B
6.49
Book value
$0.75
EPS (TTM)
$-2.57
52-week high
$16.94
52-week low
$4.19
50-day MA
$5.41
200-day MA
$8.72
Beta
1.84

Analyst view

Analysts rate Owlet Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $13.00.

Shareholding

Insiders
10.42%
Institutions
74.47%

Largest institutional holders

FundStake
ECLIPSE VENTURES, LLC26.50%
Awm Investment Company Inc6.81%
Ameriprise Financial Inc4.25%
Granahan Investment Management Inc..4.08%
Cannell Capital LLC3.43%
Vanguard Capital Management, LLC2.69%
BlackRock Inc1.11%
Renaissance Technologies Corp0.78%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Owlet Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.